Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452673
Status:
COMPLETED
Last Update Posted:
2015-03-24
First Post:
2007-03-26
Brief Title:
Phase I Study of Dasatinib BMS-354825 and Capecitabine for Women With Advanced Breast Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Organization Data
Organization:
Bristol-Myers Squibb
Class:
INDUSTRY
Study ID:
CA180-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bristol-Myers Squibb
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None